Douglas Reed

BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL.

Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.

NeuroTronik, Inc. develops medical technology for commercial operations. The company is headquartered in Chapel Hill, NC.

Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA.

Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.

GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California.

Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA.

Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina.

Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois

Embrella Cardiovascular, Inc. develops proprietary systems for embolic cerebral protection during cardiovascular procedures. The company was founded by Judith T. Carpenter and Jeffrey Francis O'Donnell, Sr. in 2007 and is headquartered in Wayne, PA.

First National Bank of Crossett provides commercial banking services. It offers personal and business banking services. The company is headquartered in Hamburg, AR.

Standard Bariatrics, Inc. operates as a surgical procedure company focused on the development and commercialization of medical devices. It offers STANDARD CLAMP, a laparoscopic surgical device designed to clamp the entire length of the stomach, enabling surgeons to plan and hold the staple line prior to dividing the stomach during laparoscopic sleeve gastrectomy. The company was founded by Jonathan Thompson in 2014 and is headquartered in Cincinnati, OH.

Qpex Biopharma, Inc. develops a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. The company is headquartered in San Diego, CA.

Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC.